Finland – Antineoplastic and immunomodulating agents – CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2025 – 31.12.202
HUS-Yhtymä awarded a contract of undisclosed value to Gilead Sciences Finland Oy for Professional Services & Consulting in February 2025 — one of 1,479 awards this buyer has made.
Buying agency
HUS-YhtymäWinning supplier
Gilead Sciences Finland OyContract description
Finland – Antineoplastic and immunomodulating agents – CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2025 – 31.12.2025
Related awards · HUS-Yhtymä
1,479 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-500745-2024Renalis Oü€40.0M21 Aug 2024 Healthcare
- ocds-ted-206235-2024Gasum Oy€35.0M08 Apr 2024 Energy
- ocds-ted-432352-2026DHL Supply Chain (Finland) Oy€25.4M25 Jun 2026 Professional Services
Other wins · Gilead Sciences Finland Oy
11 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-18491-2025HUS-Yhtymä€3.0M13 Jan 2025 Healthcare
- ocds-ted-125915-2024HUS-Yhtymä€1.2M29 Feb 2024 Professional Services
- ocds-ted-121114-2024HUS-Yhtymä€1.0M28 Feb 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for HUS-Yhtymä and Gilead Sciences Finland Oy — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back